Cargando…

Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates

BACKGROUND: With increases in antimicrobial resistance, it is crucial that patients receive appropriate antimicrobial therapy in a timely manner. Advancements in rapid diagnostics offer the ability to identify resistant organisms quickly. However, this technology is not always accessible and relies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgoon, Rachel, Hamby, Aaron, Weeda, Erin, Raux, Brian R., Hornback, Krutika M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369434/ https://www.ncbi.nlm.nih.gov/pubmed/37502247 http://dx.doi.org/10.1017/ash.2023.201

Ejemplares similares

Association between duration of antipseudomonal beta-lactam therapy and Clostridioides difficile infections in monomicrobial Enterobacterales bloodstream infections at an academic medical center
por: Hawkins, Audry M., et al.
Publicado: (2022)

Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals
por: Tseng, Chien-Hao, et al.
Publicado: (2023)

Detection of Extended-Spectrum β-Lactamases (ESBLs) and AmpC in Class A and Class B Carbapenemase-Producing Enterobacterales
por: Imkamp, Frank, et al.
Publicado: (2022)

Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022)

2826. Epidemiology of Extended Spectrum Beta-lactamase (ESBL)-producing Enterobacterales and Antimicrobial Resistance in Urinary Tract Infection (UTI) and Acute Pyelonephritis (AP)
por: Fernandez, Maria, et al.
Publicado: (2023)

Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers
por: Singh, Bhoj R
Publicado: (2018)

Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase–Producing Enterobacterales Urinary Tract Infections
por: Anderson, Daniel T, et al.
Publicado: (2022)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

1225. Optimization of Antimicrobial Therapy for Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Bloodstream Infections Through Laboratory-Based Interventions
por: Yazdi, Mona, et al.
Publicado: (2023)

Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales
por: Álvarez Otero, Judith, et al.
Publicado: (2020)

538. Extended-Spectrum β-Lactamase (ESBL): Producing Enterobacteriaceae Surveillance Pilot, New Mexico, 2017
por: Phipps, Erin C, et al.
Publicado: (2019)

Epidemiology of extended-spectrum β-lactamase–producing Enterobacterales infection in kidney transplant recipients
por: Promsuwan, Oranuch, et al.
Publicado: (2023)

The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023)

Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing Enterobacterales Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
por: Zemtsa, Ravalona Jessica, et al.
Publicado: (2022)

Risk Factors for Community Acquired Extended-Spectrum Β-lactamase (ESBL) Producing Enterobacteriaceae Urinary Tract Infections (UTIs)
por: Goyal, Dheeraj, et al.
Publicado: (2017)

1053. The β-Lactamase Inhibitor QPX7728 Restores the Activity of β-Lactam Agents against Contemporary Extended-Spectrum β-lactamase (ESBL)-Producing and Carbapenem-Resistant Enterobacterales (CRE) Isolates, Including Isolates Producing Metallo-β-lactamases
por: Lindley, Jill, et al.
Publicado: (2021)

Characterization of Extended-Spectrum β-Lactamase-Producing and AmpC β-Lactamase-Producing Enterobacterales Isolated from Companion Animals in Korea
por: Shin, Se Ra, et al.
Publicado: (2021)

Prevalence and Characterization of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Enterobacterales from Tunisian Seafood
por: Sola, Mehdi, et al.
Publicado: (2022)

Efficacy of Andrographis paniculata against extended spectrum β-lactamase (ESBL) producing E. coli
por: Rasool, Ubaid, et al.
Publicado: (2018)

Multiple Antibiotic-Resistant, Extended Spectrum-β-Lactamase (ESBL)-Producing Enterobacteria in Fresh Seafood
por: Sanjit Singh, Asem, et al.
Publicado: (2017)

Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults
por: Lewis, Joseph M., et al.
Publicado: (2022)

Reviving the role of mecillinam against extended spectrum beta-lactamase producing enterobacterales
por: Kaleem, Fatima, et al.
Publicado: (2022)

Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamase Producing Enterobacterales in Healthy Community Dogs in Israel
por: Shnaiderman-Torban, Anat, et al.
Publicado: (2022)

Fecal Microbiome Features Associated with Extended-Spectrum β-Lactamase-Producing Enterobacterales Carriage in Dairy Heifers
por: Cohen, Adar, et al.
Publicado: (2022)

Characteristics of Extended-Spectrum β-Lactamase Producing Enterobacterales Isolated from Dogs and Cats, 2011–2021
por: Woerde, Dennis J., et al.
Publicado: (2023)

2778. Retrospective evaluation of effectiveness of Flomoxef for infections due to extended-spectrum β-lactamase-producing Enterobacterales
por: Koizumi, Ryuji, et al.
Publicado: (2023)

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

Antimicrobial activity of the trans-cinnamaldehyde on nosocomial enteric bacilli producers of extended spectrum β-lactamase (ESBL)
por: Pinto, Vicente, et al.
Publicado: (2014)

Extended Spectrum β-Lactamase (ESBL) Producing Escherichia coli in Pigs and Pork Meat in the European Union
por: Bergšpica, Ieva, et al.
Publicado: (2020)

2479. Trends and Regional Differences in Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, 2012–2017
por: Wolford, Hannah, et al.
Publicado: (2019)

1454. Plazomicin Activity against Enterobacterales Isolates Producing Extended-Spectrum β-Lactamases (ESBLs), Carbapenemases, and Aminoglycoside-Modifying Enzymes (AMEs) from United States (US) Hospitals
por: Castanheira, Mariana, et al.
Publicado: (2020)

qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran
por: Pakzad, Iraj, et al.
Publicado: (2011)

Epidemiology of extended-spectrum β-lactamases in Enterobacterales in Taiwan for over two decades
por: Chao, Chien-Ming, et al.
Publicado: (2023)

Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales in healthy Spanish schoolchildren
por: López-Siles, Mireia, et al.
Publicado: (2023)

Extended Spectrum Beta-Lactamase (ESBL) Produced by Gram-Negative Bacteria in Trinidad and Tobago
por: Akpaka, Patrick Eberechi, et al.
Publicado: (2021)

Carriage and Acquisition of Extended-spectrum β-Lactamase–producing Enterobacterales Among Neonates Admitted to Hospital in Kilifi, Kenya
por: Kagia, Ngure, et al.
Publicado: (2019)

High prevalence and diversity of extended-spectrum β-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia
por: Darwich, Laila, et al.
Publicado: (2019)

Direct detection of extended-spectrum-β-lactamase-producers in Enterobacterales from blood cultures: a comparative analysis
por: Boattini, Matteo, et al.
Publicado: (2021)

Prevalence of extended-spectrum β-lactamase-producing Enterobacterales in retail sheep meat from Zagazig city, Egypt
por: Abdallah, H. M., et al.
Publicado: (2022)

2487. Which Extended-Spectrum β-Lactamase-Producing Enterobacterales Colonize the Gastrointestinal Tract of High-Risk Patients?
por: Stambaugh, Haley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0n3mnhe2djutnnhs2oqfhcglcm